NEWS: Medisafe's PATHWAYS, Eisai and Biogen Recognized for Innovation in 2025 MedTech Breakthrough Award See more
Privacy Policy | Terms of Service
Back to News & Events
The second half of 2025 brings an increasingly pressurized pharmaceutical landscape marked by potential federal mandates to slash US drug
Summary Breast cancer remains one of the most prevalent malignancies worldwide, with an estimated 287,850 new invasive cases and 43,250
Summary The cardiovascular pharmaceutical landscape constantly encounters hurdles such as medication non-adherence and fragmented patient engagement. Medisafe’s pioneering digital solutions,
We bring decades of experience to your challenges—and technology and solutions uniquely designed to meet your needs.